Clene

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Clene and other ETFs, options, and stocks.

About CLNN

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutics for neurodegenerative diseases. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. 

CEO
Robert Dee Etherington
CEORobert Dee Etherington
Employees
102
Employees102
Headquarters
Salt Lake City, Utah
HeadquartersSalt Lake City, Utah
Founded
2013
Founded2013
Employees
102
Employees102

CLNN Key Statistics

Market cap
200.67M
Market cap200.67M
Price-Earnings ratio
11.77
Price-Earnings ratio11.77
Dividend yield
Dividend yield
Average volume
190.35K
Average volume190.35K
High today
$3.23
High today$3.23
Low today
$2.91
Low today$2.91
Open price
$2.97
Open price$2.97
Volume
208.66K
Volume208.66K
52 Week high
$7.98
52 Week high$7.98
52 Week low
$1.93
52 Week low$1.93

Analyst ratings

100%

of 7 ratings
Buy
100%
Hold
0%
Sell
0%

CLNN Earnings

-$0.66
-$0.30
$0.06
$0.42
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 7, Pre-Market
ActualExpected Nov 7, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.